Shikun & Binui Energy Selects DeepSolar SaaS Starting with a 71 MW Solar Project, Reinforcing Adoption by European Infrastructure Operators ...
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
Organisations continue to adopt artificial intelligence (AI), yet many projects still falter for reasons unrelated to the technology itself. AI is advancing quickly, though it remains a tool, not a ...
In the second half of 2025, the global art market rebounded sharply (+12%). This recovery can be attributed to several factors. The United States, the world's leading art market, returned to strong ...
Mid-sized manufacturers are investing heavily in automation, but outdated ERP systems are quietly undermining those gains. Here's how AI changes that.
PRF Technologies (Nasdaq: PRFX) ("PRF" or the "Company"), through its DeepSolar AI-driven solar analytics business unit, today announced the signing ...
Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...
This novel approach integrates diverse types of information by combining clinical parameters with imaging techniques like CT scans or laboratory data.
Labs: a synergistic neural AI ecosystem driving the future through integrated research, product monetization, and accelerated AI ...
Artificial intelligence is reshaping how everyday investors build, monitor, and optimize portfolios. What used to require a human advisor, time-consuming ...
For years, Wall Street treated artificial intelligence like a familiar storyline: big promise, slow rollout, and uneven execution across industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results